Evaluation of Relapse, Efficacy and Safety of Long-term Treatment With Oracea® vs Placebo
Status:
Completed
Trial end date:
2013-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess relapse, efficacy and safety in subjects with rosacea
during long-term treatment with either Oracea® or placebo, after an initial 12-week regimen
of Oracea® and MetroGel® 1%.